![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag Biotech ![]() Related Tags Biotechnology
Business Cambridgeshire Chesterford Clinical Trials Drug Discovery Health Healthcare Life Science Life Sciences Medical Medical Device Pharma Pharmaceutical Pharmaceuticals R D Research Science Stocks Technology
| biotech News+ XML/RSSBy Adrienne O'Reilly New pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR. By ecoSolv Distribution U.S. Army’s Presidio of Monterey DFMWR Incorporates Proactive Solution to Bacteria …Long-lasting antimicrobial technology will fight bacteria growth 24/7 for up to 90 days with one application … By Cambridge Healthtech Institute CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field. By Cambridge Healthtech Institute Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference Insight Pharma Reports Announces High-Content Analysis:Technologies, Applications, & Market Dynamics By Insight Pharma Reports This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis. By Cambridge Healthtech Institute CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco. By The Global Leaders Top Healthcare, Biotech and Pharmaceutical Leaders to Meet with Investors in Search of Breakthrough Healthcare Solutions at 'The Global Leaders Healthcare Forum' on January 10 By ashley.rowe@iqpc.com IQPC’s 13th Lean Six Sigma for Pharmaceutical, Biotech, and Medical Device Excellence conference gathers industry leaders and features over 28 in-depth case studies and four workshops addressing top industry concerns By PCT Law Group, PLLC PCT Law Group announces the addition of Patrick Delaney to its Northern Virginia office. Mr. Delaney is an accomplished attorney with over 12 years of experience in patent law representing Fortune® 100 corporations and small to large companies. By The Global Leaders SAN FRANCISCO, Nov. 30, 2011 – Myrtle Potter, one of America’s foremost healthcare leaders, will speak to a unique gathering of investors and CEOs in healthcare, biotech and pharma at The Global Leaders Healthcare Forum on Tuesday, Jan. 10, 2012. By Insight Pharma Reports New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD By Yali Friedman, Ph.D. Ananda Mohan Chakrabarty and Meir Pugatch Perez join the advisory board of the Journal of Commercial Biotechnology. By Sloka PR The Institute of Life Sciences (ILS) has partnered with the Federation of Asian Biotech Associations (FABA) to scrutinize and recognize innovations through the BioAsia Innovation award and BioAsia Young Minds Award 2012. By William Adler Healthcare is in crisis throughout the world, but an innovative forum will seek solutions by connecting health, biotech and pharmaceutical CEOs and other senior executives with institutional investors and business development executives. By BioMoti BioMoti is pleased to announce the appointment of Dr Keith Powell as Chairman of the Board of Directors. By PolyGenomX - Sarah Dyson PolyGenomX Ltd announced this week that its newly incorporated sister company PolyGenomX India has signed a deal within its first week of operating with one of India's largest enterprises, the Indian Farm Forestry Development Cooperative. By Fitzsimons Redevelopment Corporatioin The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most well-known and successful leaders in the Bioscience Industry to its Board of Directors. By American Conference Institute Biotech patent circles are buzzing over the opportunity to engage USPTO patent examiners in an exclusive session at the American Conference Institute’s 13th Advanced Forum on Biotech Patents later this month in Boston. By Insight Pharma Reports New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects By IntertechPira New research from IntertechPira has identified the 25 most disruptive technologies likely to affect the industrial biotechnology industry. The developments have the potential to change the direction of the industry over the next decade All Press ReleasesBy Adrienne O'Reilly New pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR. By IntertechPira EuropaBio and IntetechPira announce call for papers for EFIB 2012 - the European Forum for Industrial Biotechnology and the Biobased economy. By Cambridge Healthtech Institute Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd. By Bioquell, Inc. The latest generation hydrogen peroxide bio-decontamination technology from Bioquell has now achieved Australian C-Tick approval. Targeted at the life sciences and healthcare markets, this unique methodology is used to eradicate microbes. By Julia Bai Through attending the annual meeting, CMCI has given excellent impressions on cow-breeding companies, and is expected to seek for further development opportunities. By Pharma IQ Industry wide economic climate study reveals bleak outlook for Pharmaceutical Industry in new report from Pharma-IQ.com By ecoSolv Distribution U.S. Army’s Presidio of Monterey DFMWR Incorporates Proactive Solution to Bacteria …Long-lasting antimicrobial technology will fight bacteria growth 24/7 for up to 90 days with one application … By Cambridge Healthtech Institute A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx. By Frost & Sullivan Technical Expertise, Potential for Time and Cost Savings Underlines Viability of Contract Outsourcing By Cambridge Healthtech Institute A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp. By Cambridge Healthtech Institute CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field. By Robert Brousseau Peptides International announces new management structure, including new President and Chief Operating officers, and Vice President, following very successful year and expanded opportunities, especially in custom peptide synthesis. By Cambridge Healthtech Institute Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference By TCD Pharma The funds will enable the Company to continue the development of TCD-717, its leading product currently in a Phase I clinical trial for the treatment of cancer, as well as expanding its pipeline. By Catherine Gorsky LifeSensors, Inc. announced today that they have appointed Dr. Mark Engleka to the position of Sales and Marketing Director. By IQPC Kim Holt, Scientific manager for Chemistry at South West Water, joins IQPC Exchange to discuss the key learnings and tools from her experience at South West Water to achieve key business objectives through smarter and more efficient data management By SignaBlok, Inc. SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). By Cambridge Healthtech Institute CHI’s Event Short Course is being held at the Molecular Med TRI-CON 2012 on February 20th at The Moscone North Convention Center in San Francisco. Insight Pharma Reports Announces High-Content Analysis:Technologies, Applications, & Market Dynamics By Insight Pharma Reports This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis. By Cambridge Healthtech Institute CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco. By Bioproximity, LLC This release of Proteome Cluster adds support for search parameter imports, sequence-based refinement for X!, Common file types and fixes IE-related bugs. By The Global Leaders Top Healthcare, Biotech and Pharmaceutical Leaders to Meet with Investors in Search of Breakthrough Healthcare Solutions at 'The Global Leaders Healthcare Forum' on January 10 By ashley.rowe@iqpc.com IQPC’s 13th Lean Six Sigma for Pharmaceutical, Biotech, and Medical Device Excellence conference gathers industry leaders and features over 28 in-depth case studies and four workshops addressing top industry concerns By IQPC Werner Kexel, Managing Director, Eurocat and BSI, joins IQPC to discuss the 3rd revision to the standards guideline 60601 and tips for medical device manufacturers on how to prepare for the changes. By IQPC Kim Holt, Scientific manager for Chemistry at South West Water, joins IQPC Exchange to discuss the key learnings and tools from her experience at South West Water to achieve key business objectives By IQPC In the last few years there has been a huge leap in the amount of intuitive and interactive technology available to individuals and organisations in order to make their lives easier. Increasingly, laboratories are leaving paper-based data management By IQPC As technology advances, software design plays an increasingly critical role in a growing number of healthcare divisions. In the global medical device industry, little has had the same level of impact on the design of software for medical devices By IQPC Enormous technological leaps have changed almost every aspect of the modern lives we lead and how our jobs are done. By PCT Law Group, PLLC PCT Law Group announces the addition of Patrick Delaney to its Northern Virginia office. Mr. Delaney is an accomplished attorney with over 12 years of experience in patent law representing Fortune® 100 corporations and small to large companies. By The Global Leaders SAN FRANCISCO, Nov. 30, 2011 – Myrtle Potter, one of America’s foremost healthcare leaders, will speak to a unique gathering of investors and CEOs in healthcare, biotech and pharma at The Global Leaders Healthcare Forum on Tuesday, Jan. 10, 2012. By Insight Pharma Reports New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD By Yudi Fernandez Binder Biomedical, DemeRx, Miami-Dade Chamber of Commerce and Specialty Telehealth Services are moving to the Miami Health District; UMLSTP’s occupancy now at 63% By Yali Friedman, Ph.D. Ananda Mohan Chakrabarty and Meir Pugatch Perez join the advisory board of the Journal of Commercial Biotechnology. By Sloka PR The Institute of Life Sciences (ILS) has partnered with the Federation of Asian Biotech Associations (FABA) to scrutinize and recognize innovations through the BioAsia Innovation award and BioAsia Young Minds Award 2012. By Green Power Conferences The BBC’s Jeremy Paxman to moderate interactive discussion on realities and myths of ongoing biofuels debate By William Adler Healthcare is in crisis throughout the world, but an innovative forum will seek solutions by connecting health, biotech and pharmaceutical CEOs and other senior executives with institutional investors and business development executives. By BioMoti BioMoti is pleased to announce the appointment of Dr Keith Powell as Chairman of the Board of Directors. By Sarah Brereton, Limewash Media & Design Ltd Peter Pan, Dick Whittington and Aladdin all turn out to raise money for Children in Need By PolyGenomX - Sarah Dyson PolyGenomX Ltd announced this week that its newly incorporated sister company PolyGenomX India has signed a deal within its first week of operating with one of India's largest enterprises, the Indian Farm Forestry Development Cooperative. By IQPC The pharmaceutical industry's 'cold chain', the controlled route along which temperature-sensitive products are distributed, plays a critical role in ensuring the shelf life and integrity of medicines and biologics. By IQPC In order to cut costs and reduce waste, organisations around the world are turning to cool chain solutions in order to take on a growing number of challenges. By Fitzsimons Redevelopment Corporatioin The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most well-known and successful leaders in the Bioscience Industry to its Board of Directors. By Sarah Brereton, Limewash Media & Design Ltd Members of the East Anglian Traction Engine Society celebrate Annual Dinner at The Nucleus, Chesterford Research Park By American Conference Institute Biotech patent circles are buzzing over the opportunity to engage USPTO patent examiners in an exclusive session at the American Conference Institute’s 13th Advanced Forum on Biotech Patents later this month in Boston. By Sarah Brereton, Limewash Media & Design Ltd Funds raised will build a new set of classrooms at the Shine Zambia Reading Academy Frost & Sullivan: Global CRO Market Revitalized Post Recession with Robust Revenue and Volume Growth By Frost & Sullivan Cost and productivity benefits ensure greater traction for CRO services By SmallCapStockPlays SmallCapStockPlays Huge Gainers Today -Titan Pharmaceuticals, Inc. (OTCBB: TTNP) up over 20% intraday, AER Energy Resources, Inc. (PINKSHEETS: AERN) up over 60% , Wild Brush Energy (PINKSHEETS: WBRE) up 30%: Join FREE Today & Get Our Next Big Pick! By Insight Pharma Reports New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects By SmallCapStockPlays SmallCapStockplays.com News Plays for October 25, 2011 are: Raystream Inc. (OTC BB: RAYS.OB), America West Resources, Inc. (OTCBB:AWSR), AlumiFuel Power Corporation (OTCBB: AFPW) By IQPC Enormous technological leaps have changed almost every aspect of the modern lives we lead and how our jobs are done. | ||||||||||||||||||||||